We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology

News   Sep 10, 2015

 
Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology
 
 
Advertisement
 

RELATED ARTICLES

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

News

Researchers have deployed a machine learning model to help drug developers on their most promising leads for attacking one of the virus’ most compelling targets –SARS-CoV-2's main protease.

READ MORE

Scientists Knock-Out All Human Genes To Identify Which Ones SARS-CoV-2 Requires

News

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

READ MORE

A Potential Diagnostic Test and Molecular Target for Machado-Joseph Disease

News

Researchers have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3), a disease that currently has no cure. The team has also have uncovered the role of a gene target linked to the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE